JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $117 | +67.1% | 63,356 | +0.5% | 0.00% | – |
| Q4 2022 | $70 | -100.0% | 63,066 | -0.1% | 0.00% | – |
| Q3 2022 | $148,000 | -14.9% | 63,129 | +9.9% | 0.00% | – |
| Q2 2022 | $174,000 | -40.4% | 57,441 | +33.5% | 0.00% | – |
| Q1 2022 | $292,000 | -21.7% | 43,035 | -3.8% | 0.00% | – |
| Q4 2021 | $373,000 | +18.0% | 44,718 | +5.0% | 0.00% | – |
| Q3 2021 | $316,000 | +12.1% | 42,573 | +2.8% | 0.00% | – |
| Q2 2021 | $282,000 | -1.4% | 41,406 | +48.7% | 0.00% | – |
| Q1 2021 | $286,000 | +41.6% | 27,847 | -3.6% | 0.00% | – |
| Q4 2020 | $202,000 | -1.9% | 28,897 | +14.4% | 0.00% | – |
| Q3 2020 | $206,000 | +2.5% | 25,262 | -13.1% | 0.00% | – |
| Q2 2020 | $201,000 | +52.3% | 29,069 | +4.8% | 0.00% | – |
| Q1 2020 | $132,000 | -40.3% | 27,735 | +9.6% | 0.00% | – |
| Q4 2019 | $221,000 | +166.3% | 25,305 | +1.1% | 0.00% | – |
| Q3 2019 | $83,000 | -27.2% | 25,029 | +9.1% | 0.00% | – |
| Q2 2019 | $114,000 | -5.8% | 22,935 | +17.1% | 0.00% | – |
| Q1 2019 | $121,000 | +86.2% | 19,590 | +2.3% | 0.00% | – |
| Q4 2018 | $65,000 | -27.0% | 19,151 | +39.4% | 0.00% | – |
| Q3 2018 | $89,000 | -21.2% | 13,741 | -6.8% | 0.00% | – |
| Q2 2018 | $113,000 | -60.5% | 14,741 | +15.0% | 0.00% | -100.0% |
| Q1 2018 | $286,000 | +113.4% | 12,817 | +22.2% | 0.00% | – |
| Q4 2017 | $134,000 | – | 10,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |